Nureca Q2 Revenue Soars 55% to ₹58.53 Crore, Highest in 20 Quarters
Nureca Limited reported its highest quarterly revenue in 20 quarters for Q2 FY27, with a 55% year-on-year increase to ₹58.53 crore. Operating profit grew 60% to ₹5.23 crore. For H1 FY27, revenue rose 37% to ₹98.87 crore, and profit after tax increased 60% to ₹7.12 crore. E-commerce contributes 88% of revenue.
The announcement details substantial revenue and profit growth, including a record quarterly revenue, which is highly material for investors and stakeholders.
The company reported record quarterly revenue and significant year-on-year growth in revenue and operating profit, indicating strong business performance.
Nureca Limited announced its unaudited consolidated results for the quarter and half-year ended 30 September 2026, reporting its highest quarterly revenue in the last 20 quarters. Revenue from operations for Q2 FY27 surged by 55% year-on-year to ₹58.53 crore, up from ₹37.74 crore in the same period last year.
Operating profit also saw significant growth, increasing by 60% to ₹5.23 crore, marking the highest operating profit in 19 consecutive quarters. Profit before tax rose by 20% to ₹5.52 crore, and profit after tax increased by 12% to ₹4.05 crore. Earnings per share (EPS) improved to ₹4.25 from ₹3.63.
For the half-year ended 30 September 2026 (H1 FY27), revenue from operations grew by 37% year-on-year to ₹98.87 crore from ₹71.92 crore. Profit after tax for H1 FY27 grew by 60% to ₹7.12 crore from ₹4.44 crore.
The company highlighted that revenue growth was broad-based across its e-commerce, quick-commerce, and offline distribution channels. Online sales increased by 55% year-on-year and quarter-on-quarter, while offline revenue grew by 90% year-on-year and 49% quarter-on-quarter. E-commerce sales accounted for 88% of the total revenue.
Nureca Limited, known for its Dr Trust, Dr Physio, and Trumom brands, also mentioned that its working capital increased during the half-year to position inventory ahead of the festive and winter season. The company remains debt-free. Saurabh Goyal, Chairman and Managing Director, commented on the strong performance.
What to do with a filing like this
Nureca Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Nureca Limited. Read the original for the full detail.